mariPOC® SARS-CoV-2 test reagent

Nom de l'organisation

ArcDia International Oy Ltd

SRN

FI-MF-000007553

Statut du fabricant

Actif

Marché principal en Finlande ; disponible dans 1 pays au total.

Commercialisé en Finlande ; dates par pays non publiées.

Dénomination commerciale

mariPOC® SARS-CoV-2 test reagent

Code d'UDI-DI

D-1R13EL

Basic UDI-DI

B-1R13EL

Numéro de référence/catalogue

1R13

Entité d'attribution

EUDAMED

Catégorie de risque

IVDD — Général

Législation applicable

IVDD [Directive 98/79/CE relative aux dispositifs médicaux de diagnostic in vitro]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

The test reagent devices consist of polystyrene microparticles as a solid phase carrier coated with affinity binders, such as monoclonal or polyclonal antibodies. specific for the analyte (antigen), and fluorescent affinity binder, such as monoclonal or polyclonal antibody, conjugates as a tracer. The immunoassay active components are dried with protective sugars and buffer components inside individual reaction chambers on test configuration packages. The mariPOC® SARS-CoV-2 test reagent is intended to be used for the detection of SARS-CoV-2 antigens when there is a suspicion of acute upper or lower respiratory tract infection, or coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2). The test reagent may be used for individuals with or without symptoms, in serial testing and in monitoring to assess the contagious phase of the infection. The SARS-CoV-2 reagent detects SARS-CoV-1 and SARS-CoV-2. The function of the device is for screening and/or aid to diagnosis in order to provide specific information on the physiological state by providing limited information on the microbiological content of the specimen. Intended specimen type is native (unprocessed) nasopharyngeal swab or aspirate. The use of the device is automated and the device is stored in dry format inside mariPOC® test plate reaction wells. The results are reported qualitatively as positive (+) or negative (−) on the graphical user interface of the mariPOC® Software.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• W0105040619CORONAVIRUSInactif

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel